Courtney M Yuen et al. review the evidence for integrated care models for #children and #adolescents with #tuberculosis 🧒👧bit.ly/3FHYUCR Stop TB Partnership #TB

J&J gets new benefit from public investment in bedaquiline. Its status as ‘essential drug’ was solidified. WHO EML: 1) endorsed use w/ pretomanid ; 2) removed age restrictions on its use. It’s time to stop depriving people of this essential med & drop all 2ary patents now.

Good to see GAP-f qTPP being highlighted by Medicines for Malaria Venture (MMV) at the EUPFI conference as an important tool to routinely assess age-appropriateness of paeds formulations in the EMLc Tiziana Masini Bernadette Cappello GAP-f

Yes!!!

Tomorrow at #ectmih2023 we'll talk about paed meds for NTDs, with Drugs for Neglected Diseases initiative World Health Organization (WHO) GAP-f Swiss TPH. Important gaps persist, and we need to do better to prioritize paed meds to meet children's needs! Join us in #utrecht if you are around, 10.30 - 12.00 at Social Impact Factory!

'R&D efforts urgently need to be streamlined and target the products that are most needed for kids. The PADO is a consensus-building process, to be sure that all... agree on the priorities for children.' Tiziana Masini at #ECTMIH2023. Read more about PADO ➡️bit.ly/49HPfud

💊Less than half of medicines for neglected tropical diseases are approved for children. World Health Organization (WHO).launches the first paediatric drug optimization report on #NTDs which prioritizes 5 specialized formulations for👶 📑👇iris.who.int/bitstream/hand…

For once let’s prioritise the neglected among the most neglected…#children with #NTD. We are ready to support! Join the efforts of our partners Drugs for Neglected Diseases initiative Medicines Development for Global Health GAP-f

Between 2012 and 2021, the 14 biggest pharms companies spent $747 billion on stock buybacks & dividends, more than the $660 billion they spent on R&D (WLazonick). Time to definancialize the health sector. #WEF24 Read the WHO Council on the Economics of Health For All final report here: who.int/publications/m…

Join us!

Assisting countries in planning and conducting programme reviews is essential to optimize their TB response. New guidance developed by Debora Pedrazzoli and colleagues describes principles and processes for programme reviews that can be adapted to local contexts.⬇️

✅ Child-friendly rifapentine (mint/raspberry flavor!) now available ✅ Can be used to facilitate administration of an important TB preventive treatment in young children 👨‍👧 👉 Want to know more about how you can access it, and discuss updates on paed TB prevention? JOIN US 👇

📢 Call for proposals to review evidence on dosing of first-line TB medicines to inform updated dosing guidance in our World Health Organization (WHO) documents 📢 Sabine Verkuijl Farai Mavhunga Kerri Viney More details ⬇ ⬇ …obaltuberculosisprogramme.cmail19.com/t/d-e-etkhdiy-…

Very surprised & impressed that Unitaid has come out *publicly* against MSF International closing the Access Campaign. UNITAID knows this is *really* bad, otherwise they wouldn't break the taboo of UN-backed agencies not commenting on the internal biz of other orgs. unitaid.org/assets/Open-le…

TB in children: MSF has been following gaps in policies and practices of countries for TB testing and treatment . As per WHO, 1.25 million children and young adolescents fall ill with TB each year, but only half of these children are diagnosed and treated. More to come soon.